Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease

Figure 3

Levels of IgA aB2GPI antibodies by age range in pretransplant samples versus blood donors. Cut-off is shown with a dotted line.